Doctors Note Logo

Published on: 10/1/2026

What the measles vaccine is called, and how MMR and MMRV differ

The measles vaccine is not sold alone in the U.S.; it comes as a combination shot called MMR (measles, mumps, rubella) or MMRV (measles, mumps, rubella, varicella/chickenpox, brand name ProQuad), with MMR licensed for ages 6 months and older and MMRV only for children 12 months through 12 years. The key difference is that MMRV means one fewer injection but carries a slightly higher risk of fever and febrile seizure in younger children, which is why CDC prefers separate MMR and varicella shots for the first dose before age 2. Dose timing, age, pregnancy, immune status, travel plans, and prior infection all change what is recommended for you, so see below for the complete details before deciding.

If you are weighing vaccination because you already have a fever, rash, cough, or red watery eyes, knowing whether your symptoms point toward measles or something far more common changes how urgently you should act, since measles spreads before the rash appears and requires calling ahead rather than walking into a waiting room. Take a free, instant, online symptom check to see what your symptoms may indicate and get clear guidance on your next steps.

Last reviewed for medical accuracy: 10/01/2026

answer background

Explanation

What Is the Measles Vaccine Called?

The measles vaccine is most commonly administered as part of a combination shot known as MMR, which protects against Measles, Mumps, and Rubella. In some cases, children receive MMRV, which adds protection against Varicella (chickenpox). Below, you’ll find clear, concise information about these vaccines, how they differ, and what to expect.


Measles Vaccine Names and Brands

  • MMR
    • Generic name: Measles, Mumps, Rubella vaccine
    • Common U.S. brand: M-M-R II
    • International brand: Priorix
  • MMRV
    • Generic name: Measles, Mumps, Rubella, Varicella vaccine
    • Common U.S. brand: ProQuad

Why Combine Measles with Other Vaccines?

Combining vaccines into a single shot offers multiple benefits:

  • Fewer injections
  • Improved immunization rates
  • Efficient use of healthcare resources
  • Reduced stress for children and caregivers

MMR: Measles, Mumps, Rubella

What It Contains

  • Live, attenuated (weakened) viruses for:
    • Measles (rubeola)
    • Mumps
    • Rubella (German measles)

Typical Schedule

  1. First dose: 12–15 months of age
  2. Second dose: 4–6 years of age (before kindergarten)

Effectiveness

  • Measles: ~97% protected after two doses
  • Mumps and Rubella: similarly high protection rates

Common Side Effects

  • Mild fever
  • Injection-site redness or swelling
  • Temporary rash (in a small percentage)

Most side effects are mild and resolve within a few days.


MMRV: Measles, Mumps, Rubella, Varicella

What It Contains

  • Live, attenuated viruses for:
    • Measles
    • Mumps
    • Rubella
    • Varicella (chickenpox)

Typical Schedule

  • Can be given at 12–15 months, replacing the MMR + Varicella separate shots
  • Second dose at 4–6 years

Effectiveness

  • Comparable to separate MMR and varicella shots
  • One study showed ~96% protection against varicella after two doses

Common Side Effects

  • Slightly higher rate of fever and rash compared to MMR alone
  • Rare risk (about 1 in 2,000) of febrile seizure between days 5–12 after the first dose

Key Differences Between MMR and MMRV

  • Components
    • MMR: measles, mumps, rubella
    • MMRV: adds varicella
  • Injection Count
    • MMR + separate varicella: two shots at one visit
    • MMRV: single shot
  • Side-Effect Profile
    • MMRV may have a slightly higher chance of fever and rash after the first dose
    • Risk of febrile seizure is still very low
  • Convenience
    • MMRV reduces the number of injections

Who Should Receive Which Vaccine?

  • MMR
    • Preferred if there’s a family history of seizures or other neurologic conditions
    • If you want to space out vaccines
  • MMRV
    • Convenient for on-time, combined protection
    • Ideal for families preferring fewer injections

Always discuss your child’s medical history and any concerns with your healthcare provider.


Safety and Monitoring

  • Live vaccines are rigorously tested in large clinical trials before approval.
  • The CDC and WHO continuously monitor vaccine safety data.
  • Serious side effects (anaphylaxis, seizure) are extremely rare (fewer than 1 in 100,000 doses).

What to Do If You’re Unsure About Symptoms

If you or your child develops concerning symptoms—high fever, difficulty breathing, severe rash—please seek medical attention immediately. You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help decide your next steps.

Use the free, online symptom check, using the doctor approved Ubie Symptom Checker


Talking with Your Doctor

  • Review your or your child’s vaccination history
  • Discuss any allergies or prior reactions to vaccines
  • Plan the best vaccination schedule for your family
  • Report any severe side effects promptly

Final Thoughts

Vaccination against measles is a critical step in protecting individual and public health. Whether you choose MMR or MMRV, you’re aiming to prevent serious illnesses like measles encephalitis or pneumonia. Always:

  1. Ask your healthcare provider if you have any questions.
  2. Use reliable resources and avoid misinformation.
  3. Speak to a doctor about anything that could be life threatening or serious.

By staying informed, you help keep your community safe and healthy.

(References)

  • * Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2006 Oct;28(8):533-91. PMID: 17136234.

  • * Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2009 Mar;31(2):107-46. PMID: 19455266.

  • * Langan RC, Moher HE. Photo quiz. Infant with a morbilliform rash. MMRV vaccine adverse reaction. Am Fam Physician. 2010 Feb 1;81(3):327. PMID: 20112891.

  • * Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2010 Dec;32(10):749-73. doi: 10.1358/mf.2010.32.10.1573763. PMID: 21225012.

  • * Lee AM, Burns JC, Tremoulet AH. Safety of Infliximab Following Live Virus Vaccination in Kawasaki Disease Patients. Pediatr Infect Dis J. 2017 Apr;36(4):435-437. doi: 10.1097/INF.0000000000001447. PMID: 27918378.

  • * Cashman P, Moberley S, Durrheim D. MMRV vaccine safety. Vaccine. 2019 Jul 9;37(30):3946. doi: 10.1016/j.vaccine.2018.02.108. Epub 2018 Mar 8. PMID: 29526373.

  • * Vaccines for travelers. Med Lett Drugs Ther. 2018 Nov 19;60(1560):185-192. PMID: 30625125.

  • * Toplak N, Uziel Y. Vaccination for Children on Biologics. Curr Rheumatol Rep. 2020 May 20;22(7):26. doi: 10.1007/s11926-020-00905-8. Epub 2020 May 20. PMID: 32436130.

  • * Itzhaki Gabay S, Samueli B, Test G, Valdman-Grinshpoun Y, Horev A. Infantile Sweet syndrome following MMRV vaccine. Pediatr Dermatol. 2023 Jan;40(1):207-209. doi: 10.1111/pde.15162. Epub 2022 Nov 13. PMID: 36373208.

  • * Rueda MS, Hutto C, Hobby-Noland D, Song X. When Vaccination Meets Infection Prevention: National Practices for Inpatient Administration of Measles-Mumps-Rubella, Varicella, and Rotavirus Vaccines. J Pediatric Infect Dis Soc. 2026 Sep 14;15(9). doi: 10.1093/jpids/piag091. PMID: 42720270.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.